In NPC, previous studies have explored the potential involvement of the NLRP3 inflammasome.9, 10 Our prior work also identified the NLRP3/caspase-1/GSDMD pathway as a key biomarker for predicting NPC recurrence and metastasis.11 Here, CASP1 is linked to nasopharyngeal carcinoma.